baber/WOPTO huggingface dataset:
Patent JP-2001511055-A (JP)
Title: スピンバスケット内に洗濯水を噴射する装置を備えた洗濯機
IPC: D06F39/08
Filed: 1998-12-03
Abstract: (57)【要約】
洗濯機はモータ（１１）により回転駆動されるスピンバスケット（２）を有している。スピンバスケットの外側には給水管から水が供給されるバレル（２５）が設けられており、バレル内にはノズル（３０）が設けられている。ノズルはスピンバスケット内に水を噴射する多数の散水孔（３２）を備え、スピンバスケットの開口部に隣接するようにバレルから突出する突出位置と開口部から離隔されるようにバレル内に挿入される挿入位置との間を移動可能に設けられている。ノズルはスプリングにより挿入位置に向かって弾性加圧される。弁より給水管が開放されると、給水管を通じてバレル内に流入した水の水圧によりノズルがスプリングの弾性力に抗して突出位置に移動する。これにより散水孔を通じて水がスピンバスケット内にシャワー給水方式で噴射される。従って、濯ぎ作用が効率よく行われる。
Patent JP-H11504058-A (JP)
Title: 固形洗剤
IPC: C11D1/92
Filed: 1996-04-12
Abstract: (57)【要約】
イセチオネートおよびポリアルキレングリコールを含む固形合成洗剤組成物。かかる組成物への有機アミドの添加は、相分離の防止を助勢することが分かった。
Patent JP-2001513769-A (JP)
Title: アシアト酸誘導体を有効成分とする肝保護および治療剤
IPC: A61K31/215
Filed: 1998-02-28
Abstract: (57)【要約】
本発明は、下記化学式1で表されるアシアト酸誘導体およびその薬剤学的に許容される塩およびエステルを有効成分として含む、肝保護および治療剤に関する。
Patent JP-H11508755-A (JP)
Title: 無線トランシーバの伝送パワーレベルを制御するハイブリッド・アナログ／デジタル方法および装置
IPC: H03G3/30
Filed: 1996-05-01
Abstract: (57)【要約】
トランスミッタ、特に無線パーソナル通信システムの伝送パワーレベルを制御する技法を開示する。この技法はトランシーバ間の干渉が伝送品質を低下させるのを防止するのを援助する。伝送パワーレベル（１７０−１７２）はデジタルおよびアナログ両方の電子機器を含んでいるハイブリッド回路によって制御される。伝送パワーレベルはデータ・ストリームが圧縮される量と、アナログ伝送パワー増幅器（１６０）のゲインの両方を制御することによって設定される。この手法は伝送パワーレベルに対する適正な制御を可能とし、この手法によれば、デジタル伝送信号に極めて広いデータパスを利用する（これは携帯端末のバッテリ消費量を軽減させることがある）必要もないし、高価で構成が困難なアナログ電子機器を利用する必要もない。
Patent JP-2000514836-A (JP)
IPC: C12N5/10
Filed: 1998-03-27
Abstract: Amphipathic lytic peptides are ideally suited to use in a ligand/cytotoxin combination to specifically inhibit cells that are driven by or are dependent upon a specific ligand interaction; for example, to induce sterility or long-term contraception, or to attack tumor cells, or to selectively lyse virally-infected cells, or to attack lymphocytes responsible for autoimmune diseases. The peptides act directly on cell membranes, and need not be internalized. Administering a combination of gonadotropin-releasing hormone (GnRH) (or a GnRH agonist) and a membrane-active lytic peptide produces long-term contraception or sterilization in animals in vivo. Administering in vivo a combination of a ligand and a membrane-active lytic peptide kills cells with a receptor for the ligand. The compounds are relatively small, and are not antigenic. Lysis of gonadotropes has been observed to be very rapid (on the order of ten minutes). Lysis of tumor cells is rapid. The two components -the ligand and the lytic peptide- may optionally be administered as a fusion peptide, or they may be administered separately, with the ligand administered slightly before the lytic peptide, to activate cells with receptors for the ligand, and thereby make those cells susceptible to lysis by the lytic peptide. The compounds may be used in gene therapy to treat malignant or non-malignant tumors, and other diseases caused by clones or populations of "normal" host cells bearing specific receptors (such as lymphocytes), because genes encoding a lytic peptide or encoding a lytic peptide/peptide hormone fusion may readily be inserted into hematopoietic stem cells or myeloid precursor cells.
Patent MD-20000101-A (MD)
Title: Polymerisable composition provided for coating the metallic surfaces with an organic cover, process for obtaining said composition, processes for coating
Inventor: SCHIEFERSTEIN LUDWIG
IPC: C09D4/00
Filed: 1998-11-10
Abstract: The invention relates to prolymerisable composition for coating of metallic materials with an organic cover, process for obtaining thereof and process of steel wrapping coating.Summary of the invention consists in the fact that the polymerisable composition contains titanium, manganese and/or zirconium salts of some carboxylic olefinically unsatulated polymerisable acids and other olefinically unsaturated comonomers, as well as a radical polymerization initiator suitable for the organic coil coating of metallic materials.
Patent MD-20030181-A (MD)
Title: Process for obtaining blanks from ingots of large sections and rotary steadyrest for realization thereof
Inventor: MATVEENCO DMITRII
IPC: B23Q1/76
Filed: 2003-07-21
Abstract: The invention relates to the metal machining, namely to devices for fixation of blanks from round bars.The process includes fixation of the blank from round bars into the steadyrest and subsequent machining thereof.The steadyrest includes, fixed onto a bedplate, two vertical posts joined by a distance cross-piece. Into each post there are installed bearing supports, wherein there is mounted a rotary bearing element, made in the form of a pipe, onto the ends of which, on both sides of the vertical posts, there are placed blank fixating devices, each of which is provided with pressure bolts. The steadyrest additionally contains, fixed onto one of the posts, an arm for supporting the free end of the blank.
Patent MX-143135-A (MX)
Inventor: DENMAN LEE RICHARD
IPC: F16L1/12
Filed: 1977-07-08
Abstract: A B R I D G M E N T An offshore pipe laying vessel has a rigid pipe supporting stern ramp with rollers at spaced intervals for supporting pipe being launched from the vessel on its over bend.  Load cells measure reaction loads of the pipe on the rollers.   The reaction loads are displayed for monitoring.
Patent MX-151453-A (MX)
Inventor: TAIG ALISTAIR GORDON
IPC: F16C1/22
Filed: 1982-07-05
Abstract: A locking device (30) for attachment to an elongate member (28) to secure the latter to a fixed support (18) in an adjustable axial position; 
<??>The locking device according to the invention comprises a first part (32) slidably carried on the elongate member but prevented from rotating relative thereto, and a second part (34) which, in a first angular position, is axially movable together with the first part along the elongate member, and in a second angular position meshes with teeth formed on said member to secure said second part in an axial, selected position; 
<??>For use particularly in transmission and clutch cable assemblies.
Patent NZ-201205-A (NZ)
Title: Process for the preparation of penam derivatives
Inventor: DALES J R M
IPC: C07D499/04
Filed: 1982-07-08
Abstract: A process for the preparation of a penam derivative of formula (I): <IMAGE> (I)  wherein RA is hydrogen or a group of formula (Ia): <IMAGE> (Ia)  wherein X is -CO2R1, or SO3R1; R is C1-6alkyl, aryl, or heterocyclyl; R1 is hydrogen, or a pharmaceutically acceptable salt-forming ion or ester-forming radical, and R2 represents hydrogen or a pharmaceutically acceptable salt-forming ion or in vivo hydrolyzable ester-forming radical; which process comprises reacting a compound of formula (II):    <IMAGE> (II)  wherein RB is hydrogen, a removable amino blocking group, or a group of formula (IIa): <IMAGE> (IIa)  wherein Y is -CO2Rx or -SO3Rx; R is as defined with respect to formula (I) above; Rx represents an ester-forming radical, RY represents hydrogen, a salt-forming radical or a carboxyl-blocking group, and R3 represents an alkyl, benzyl, or aryl group; with methanol in the presence of copper ions; and thereafter if necessary carrying out one or more of the following steps: (i) removal of any blocking group; (ii) converting the product to a pharmaceutically acceptable salt or ester thereof.
Patent NZ-212538-A (NZ)
Title: Biodegradable amphipathic copolymers and pharmaceutical compositions
Inventor: CHURCHILL J R
IPC: C08G63/66
Filed: 1985-06-25
Abstract: A pharmaceutically or veterinarily acceptable amphipathic, non-cross linked linear, branched or graft block copolymer, which has a minimum weight average molelcular-weight of 1000, in which the hydrophobic component is biodegradable or hydrolytically unstable under normal physiological conditions, and the hydrophilic component may or may not be biodegradable or hydrolytically unstable under such conditions, and which copolymer is self-dispersible in water; together with mixtures of such a copolymer and a drug, which may be water-soluble or water-insoluble, which mixtures are self-dispersible in water; and processes for the manufacture of such copolymers and such mixtures.
Patent NZ-218203-A (NZ)
Title: Arched roof with sliding panel sections
Inventor: LEURENT G H
IPC: E04B1/32
Filed: 1986-11-06
Abstract: An openable covering structure for any desired location which is particularly well adapted for use in conjunction with a swimming pool, comprising several covering elements extending above the basin of the swimming pool and movable relative to one another. Each covering element comprises two parallel arches between which extend transparent or translucent covering plates. To make the opening operations easier and to extend the opening possibilities, each arch of a covering element has, in at least one of its front vertical faces, at least three parallel and superimposed grooves which extend over the entire length of the arch and in which are respectively fitted at least three covering plates mounted in the grooves so as to be capable of transversely sliding.
Patent NZ-219633-A (NZ)
Title: Extended release solid preparation
Inventor: FALK K-E L
IPC: A61K9/42
Filed: 1987-03-16
Abstract: An extended release preparation of an active compound with very low solubility containing the active compound dissolved or dispersed in a semi-solid or liquid non ionic solubilizer and whereby the amount by weight of the solubilizer is at least equal to the amount by weight of the active compound as well as a process for the preparation thereof.
Patent NZ-226591-A (NZ)
Title: Preparation of cyclobutarenes by steam pyrolysis of substituted benzene or naphthalene derivatives
Inventor: QUARDERER GEORGE J
IPC: C07C1/28
Filed: 1988-10-17
Abstract: Cyclobutarenes are prepared by pyrolyzing a suitable benzene, naphthalene, or pyridine derivative in the presence of an amount of steam effective to substantially reduce the partial pressure of the pyrolyzing compound.
Patent NZ-228587-A (NZ)
Title: (maif) milk anti-inflammatory factor, its isolation and purification
Inventor: BECK LEE R
IPC: A61K35/54
Filed: 1989-04-03
Abstract: An anti-inflammatory factor can be isolated from milk collected from a milk-producing animal. The factor may be isolated from milk is produced by a milk-producing animal maintained in a hyperimmunized state.
Patent NZ-232646-A (NZ)
Title: Manufacture of tobacco rod for cigarettes with longitudinal channel formed in rod
Inventor: HULSMAN SEVERIEN
IPC: A24D1/00
Filed: 1990-02-22
Abstract: A method and apparatus for manufacturing a rod of tobacco or the like enclosed by a paper strip (9) is described, wherein a paper strip is supported and transported by a garniture tape (1) and tobacco (10) is deposited on the paper strip. The tobacco is compressed into a tobacco core (11) and the paper strip is closed with its longitudinal edges parts (12, 13) around the compressed tobacco core. A channel (14) is formed in the circumference of the tobacco rod during the compressing by means of an entrance finger (15) with a ridge (17). A second longitudinal edge part (13) of the paper strip is folded into the channel by a folding element (19) and a first longitudinal edge part (12) is subsequently laid over said channel.
Patent NZ-234428-A (NZ)
Title: Use of an amylin antagonist in the treatment of obesity and essential hypertension
Inventor: COOPER GARTH J S
IPC: A61K38/00
Filed: 1990-07-10
Abstract: The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis.
Patent NZ-235025-A (NZ)
Title: Dibenzoxepin derivatives: pharmaceutical compositions and preparatory processes
Inventor: ALLEN RICHARD C
IPC: A61K31/335
Filed: 1990-08-23
Abstract: This invention relates to N-hydroxy-dibenz[b,e]oxepinalkylamines, N-hydroxy-dibenz[b,e]oxepinalkanoic acid amides and related heterocyclic analogues of the formula <CHEM> where X together with the carbon atoms to which it is attached forms a benzene or thiophene ring; W and Z are independently hydrogen, halogen, loweralkyl, or trifluoromethyl, R<1> is hydrogen, loweralkyl, or acyl; R<2> is hydrogen, loweralkyl, cycloalkyl, arylloweralkyl or acyl; m is 0 or 1 and n is an integer of 0 to 12 and the pharmaceutically acceptable salts thereof. The compounds of this invention exhibit dermatological and analgesic activity.
Patent NZ-238430-A (NZ)
Title: Aqueous compositions which gel reversibly as temperature and ph change (containing two suitable polymers); use as a carrier for medicaments
Inventor: ABHAY JOSHI
IPC: A61K9/06
Filed: 1991-06-06
Abstract: Reversibly gelling aqueous and oil emulsions are disclosed which can be modified to incorporate oil soluble pharmaceutical compounds for delivery to physiological systems in a soluble form and which undergo significant changes in viscosity in response to substantially simultaneous changes in both temperature and pH. The compositions are formed of relatively low concentrations of a stable combination of at least one pH-sensitive reversibly gelling polymer, at least one temperature-sensitive reversibly gelling polymer and at least one organic oil. The compositions can be formulated to exhibit a sol-gel transition over a wide range of conditions and viscosities and may be modified to incorporate a pharmaceutical compound for utilization as droppable or injectable drug delivery systems which will gel following administration to a physiological system for the sustained delivery of such pharmaceutical compounds.
Patent NZ-242258-A (NZ)
Title: Low-fat frozen confection product; method of manufacture
Inventor: BRACEY JOHN DOUGLAS
IPC: A23G9/34
Filed: 1992-04-07
Abstract: A method of manufacturing frozen confection products without any appreciable overrun by slush freezing an ice mix comprising up to 10% and preferably from 0 to 0.5% of fat and comprising 0.2 to 0.5% of overrun restricting stabilizer and thereafter freezing hard to a usual storage temperature. A frozen confection without any appreciable overrun and containing up to 8 to 10% fat but preferably being fat-free, having a melt down rate of at most 0.175 g/min between 4 and 24% weight loss and a total weight loss of 30 to 80%, determined with a cylindrical sample of 2.5 cm diameter weighing 10 g, equilibrated at -20 DEG C and exposed to an ambient temperature of 18 DEG  to 20 DEG C while supported on a horizontal steel wire netting of 2.5 x 2.5 mm mesh size.
Patent NZ-248451-A (NZ)
Title: Treatment and/or prophylaxis of abnormal calcification of body tissue by administration of gamma-linolenic acid and/or eicosapentaenoic acid and/or metabolites and precursors thereof
Inventor: HORROBIN DAVID FREDERICK
IPC: A61K31/20
Filed: 1993-08-20
Abstract: Prevention and/or treatment of abnormal calcification in any tissue by the administration of (i) GLA and/or its EFA metabolites, and in particular the rapidly produced DGLA and/or (ii) EPA and/or its precursors, stearidonic acid and 20:4 n-3, and metabolites, docosahexaenoic acid (DHA) or docosapentaenoic acid (22:5 n-3), as such or in salt or other pharmacologically acceptable form. This is especially suitable for prevention or treatment of nephrocalcinosis and/or renal stones.
Patent NZ-264605-A (NZ)
Title: Protocols and time slot groupings for mobile wireless telephony
Inventor: RAITH ALEX K
IPC: H04L12/56
Filed: 1994-10-04
Abstract: A method for obtaining a report from a mobile station on the status of frames comprising an entire message transmitted to the mobile station is disclosed. First, a polling request is sent to the mobile station from a base station. A status report is then sent to the base station. The polling request specifies whether the mobile station should send the status report on a reservation basis (using a reserved frame) or on a contention basis (using an idle frame). The mobile station then transmits a bit map to the communication system to indicate which frames have been correctly received by the mobile station at the point when it received the polling request.
Patent NZ-336768-A (NZ)
Title: A method of characterising polypeptides comprising cleaving polypeptide with a cleaving agent, isolating peptide fragments (followed by a second cleavage and biotinylation step) and determining the mass spectrometry (MS) signature sequence
Inventor: SCHMIDT GUNTER
IPC: C07K1/04
Filed: 1998-01-23
Abstract: A method for characterising polypeptides, which comprises: (a) treating a sample comprising a population of one or more polypeptides with a cleavage agent which is known to recognize a specific amino acid residue or sequence in polypeptide chains and to cleave at a cleavage site, whereby the population is cleaved to generate peptide fragments; (b) isolating a population of the peptide fragments which bear at one end a reference terminus comprising either only a C-terminus or only an N-terminus and which bear at the other end the cleavage site proximal to the reference terminus; and c) determining a signature sequence of at least some of the isolated fragments, which signature sequence is the sequence of a predetermined number of amino acid residues running from the cleavage site; wherein the signature sequence and the relative position of the cleavage site to the reference terminus characterize the polypeptide or each polypeptide.
Patent NZ-502660-A (NZ)
Title: Pyrimidyl- or (oxazolyl- or thiazolyl-)oxy substituted carboxylic acid derivatives useful as mixed ETA/ETB endothelin-receptor antagonists
Inventor: RASCHACK MANFRED
IPC: C07D263/38
Filed: 1998-08-24
Abstract: A carboxylic acid derivative or a physiologically tolerated salts or enantiomerically pure forms thereof has the formula (I) wherein: R is tetrazole or -C(O)-R1; R1 is OR7, cycloalkyl, alkyl, or optionally substituted CH2-phenyl, alkenyl, alkynyl or phenyl; R4 and R5 are independently optionally substituted phenyl or naphthoyl or phenyl or naphthyl which are linked together in the ortho positions by a direct linkage, methylene, ethylene or ethenylene, oxygen, sulphur, SO2, NH or N-alkyl; R6 is H, or optionally substituted alkyl, alkenyl, alkynyl, phenyl, naphthyl, a five or six membered heteroaromatic system comprising one to three nitrogens and/or sulphur or oxygen or cycloalkyl; Z is sulphur or oxygen; B is alkylene; Het is a heterocyclic radical of formula Ia or Ib'; R2 is H, OH, N(R')2, halo, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, haloalkoxy, alkylthio or CR2 is linked to C10 to form a 5 or 6 membered ring defined below or if Het is a 5 membered ring, CR2 together with CR3 can be an optionally substituted 5- or 6- membered alkenyl or alkylenyl ring; X and Y are independently nitrogen or methane; W is nitrogen or CR10; R10 is H, halo or alkyl or CR10 forms together with CR2 or CR3 an optionally substituted 5 or 6 membered alkylene or alkenylene ring wherein one or more of the methylene groups can be replaced by oxygen, sulphur or NR'; R3 is H, OH, N(R')2, halo, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, halolkoxy, alkylthio or CR3 is linked to C10 to form a 5 or 6 membered ring defined above; R' is H or alkyl; T is O, S or NR8 and R8 is alkyl. A pharmaceutical composition thereof is useful as an endothelin receptor antagonist.
Patent NZ-502793-A (NZ)
Title: Guardrail end terminal for side or front impact with reactor plate at three to four inches above ground level to receive floor structure of vehicle during impact
Inventor: BRONSTAD MAURICE E
IPC: E01F15/14
Filed: 1998-07-10
Abstract: The end terminal has a system for transferring forces from a floor structure of a vehicle to beams (110-112) on the energy-absorbing guardrail end terminal during a side impact with the vehicle. The system for transferring forces includes a spacer channel (136) attached between first and second guardrails and a force transfer (102) member coupled to the spacer channel and having a portion extending to a position above ground level to receive a floor structure of a vehicle during a forceful side impact. A method of manufacturing a system for transferring forces from a floor structure of a vehicle to a guardrail end terminal during a forceful side impact includes attaching a force transfer member that extends to a position to engage the floor structure.
Patent NZ-508560-A (NZ)
Title: Use of prostaglandin agonists to treat erectile dysfunction or impotence
Inventor: LEFKER BRUCE ALLEN
IPC: A61K31/197
Filed: 2000-12-01
Abstract: A method for treating importance or erectile dysfunction by administering prostaglandin receptor agonist compounds of formulae (I), (II), (III) and (IV) described in the specification: Compound of formula (I) is described herein, where: B is N; A is optionally substituted (C1-C6)alkylsulfonyl, (C3-C7)cycloalkylsulfonyl, or (C3-C7)cycloalkyl(C1-C6)alkylsulfonyl; Z is carboxyl, alkylcarbonyl, tetrazolyl, 1,2,4-oxadiazolyl, 5-oxo-1,2,4-oxadiazolyl, alkylsulfonylcarbamoyl or phenylsulfonylcarbamoyl; K is a bond, an optionally substituted alkylene, thioalkylene or oxyalkylene; Q and M are described in the complete specification. For formulae (II), (III) and (IV) A, B, K, M, Z, Q, G, L R, R1, R2, R3, R4 and R5 are described in the complete specification.
Patent NZ-509052-A (NZ)
Title: Device for controlling fuel injection quantity and method of controlling fuel injection quantity for an internal combustion engine equipped with turbocharger
Inventor: IMAI YOSHINARI
IPC: F02D41/02
Filed: 2000-03-31
Abstract: A device and method for controlling the fuel injection amount  of  an internal combustion engine with turbocharger, wherein  it  is  investigated whether or not a supercharging pressure  Pb  rises to a specified value  P0  or  higher  to judge  whether  a trouble occurs or not with a supercharging pressure  regulating mechanism and, when it is  judged  that any  trouble does not occur with the supercharging  pressure regulating mechanism, a fuel injection amount Tp  in  normal state  is  calculated based on the operating  conditions  of the  engine, whereas, if it is judged that a trouble  occurs with   the   supercharging  pressure  mechanism,  the   fuel injection amount Tp in failure state which is less than  the fuel  injection  amount in normal state is  calculated,  and then  fuel  injection  control is  performed  based  on  the calculated fuel injection amount in normal state Tp  or  the fuel  injection amount in failure state TP, whereby, if  any trouble  occurs  with the supercharging pressure  regulating mechanism,  the  fuel injection amount will be  reduced  and the  supercharging pressure can be controlled  to  below  an allowable  upper  limit  through a  reduction  in  generated torque.
Patent NZ-511197-A (NZ)
Title: Method for monitoring proteasome inhibitor drug action
Inventor: ADAMS JULIAN
IPC: C12Q1/37
Filed: 1999-10-19
Abstract: A method for monitoring pharmacodynamic drug action of a proteasome inhibitor in a mammal, comprises a) obtaining one or more test biological samples from the mammal at one or more specified times after administering the proteasome inhibitor; b) measuring proteasome activity in the test biological sample(s); c) determining the amount of proteasome activity in the test biological sample(s); and d) comparing the amount of proteasome activity in the test biological sample to that in a reference biological sample obtained from a mammal to which no proteasome inhibitor has been administered. This method is also used to determine a dose regimen for a proteasome inhibitor and determining a baseline a proteasome activity in a mammal.
Patent NZ-511587-A (NZ)
Title: A process for controlling the solidification and/or crystallisation of a fat or a fat-containing food
Inventor: BECKETT
IPC: C11B15/00
Filed: 1999-12-06
Abstract: A process for controlling the solidification and/or crystallization of a cocoa butter-containing food under the influence of a magnetic field, allowing said food product to be produced in form V or form VI (of the six possible crystal forms of cocoa butter) directly from liquid phase, thereby eliminating certain costly steps such as the necessity to utilize cooling tunnels.